Health Sciences Acquisitions Corporation 2 (HSAQ) Stock
Health Sciences Acquisitions Corporation 2 currently lacks active business operations. Its primary objective is to complete a strategic business combination, such as a merger or acquisition, with one or more enterprises.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Health Sciences Acquisitions Corporation 2
Health Sciences Acquisitions Corporation 2 currently lacks active business operations. Its primary objective is to complete a strategic business combination, such as a merger or acquisition, with one or more enterprises. These target businesses will operate within the biopharmaceutical or medical technology sectors and be located in North America or Europe. The company was established in 2020 and is headquartered in New York, New York.
Health Sciences Acquisitions Corporation 2 is headquartered in US.
Health Sciences Acquisitions Corporation 2 (HSAQ) stock trades at $13.31 with a market capitalization of $149.23M. The stock is valued at a price-to-earnings (P/E) ratio of -14.01, price-to-book of 20266.75, price-to-sales of 4.56. Over the past 52 weeks the stock has ranged between $9.41 and $13.80, and currently trades 3.6% below its 52-week high.
On profitability, Health Sciences Acquisitions Corporation 2 generates a return on equity (ROE) of -158.09%, return on capital employed of -63.20%, an operating margin of -167.96%, a net profit margin of -167.63%.